Suchergebnisse - "Chilton, Robert J"

PubPharm (81)

11

SGLT2 inhibitors : a narrative review of efficacy and safety

enthalten in: Journal of osteopathic medicine | 2021

von Nelinson, D. | Sosa, J. | Chilton, R.

12

The role of rivaroxaban for patients with atherosclerotic vascular disease in the modern era

enthalten in: Catheterization and Cardiovascular Interventions | 2021

von Vogt, J. | Manning, P. | Sheikh, O. | +3

13

Beyond the myocardium : Sodium‐glucose co‐transporter‐2 inhibitors in heart failure

enthalten in: Diabetes, Obesity and Metabolism | 2021

von Chilton, R.

14

Cardiovascular risk and the implications for clinical practice of cardiovascular outcome trials in type 2 diabetes

enthalten in: Primary care diabetes | 2020

von Chilton, R. | Dungan, K. | Shubrook, J. | +1

15

Cardiorenal protection with SGLT2 : Lessons from the cardiovascular outcome trials

enthalten in: Journal of diabetes | 2020

von Silva-Cardoso, J. | Sheikh, O. | Nashawi, M. | +4

16

Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetes

enthalten in: Diabetes, obesity & metabolism | 2020

von Chilton, R.

17

Effects of sodium‐glucose cotransporter‐2 inhibitors on the cardiovascular and renal complications of type 2 diabetes

enthalten in: Diabetes, Obesity and Metabolism | 2020

von Chilton, R.

18

PCSK9 inhibitors and diabetes : Translational biology to clinical practice

enthalten in: Diabetes, obesity & metabolism | 2019

von Chilton, R. | Oliveros, R. | Gallegos, K. | +1

19

PCSK9 inhibitors and diabetes : Translational biology to clinical practice

enthalten in: Diabetes, Obesity and Metabolism | 2019

von Chilton, R. | Oliveros, R. | Gallegos, K. | +1

20

The Evolving Role of the Cardiologist in the Management of Type 2 Diabetes

enthalten in: Current diabetes reports | 2018

von Chilton, R. | Gallegos, K. | Silva-Cardoso, J. | +2